CGON vs. DY
CGON (CG Oncology, Inc) and DY (Dycom Industries, Inc.) are both stocks. CGON operates in Biotechnology (Healthcare), while DY operates in Engineering & Construction (Industrials). Over the past year, CGON returned 170.58% vs 52.33% for DY. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
CGON vs. DY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CGON achieves a 71.46% return, which is significantly higher than DY's 18.69% return.
CGON
- 1D
- -2.52%
- 1M
- 1.18%
- 6M
- 36.77%
- YTD
- 71.46%
- 1Y
- 170.58%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 42.95%
DY
- 1D
- -3.85%
- 1M
- -8.38%
- 6M
- 10.07%
- YTD
- 18.69%
- 1Y
- 52.33%
- 3Y*
- 58.45%
- 5Y*
- 42.03%
- 10Y*
- 15.82%
- ALL TIME*
- 13.01%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CGON CG Oncology, Inc | $59.82M | $66.58M | $70.32M |
| $195.20M | $192.79M | $262.31M |
CGON vs. DY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CGON CG Oncology, Inc | 71.46% | 44.77% | -1.10% |
DY Dycom Industries, Inc. | 18.69% | 94.13% | 53.78% |
Correlation
The correlation between CGON and DY is 0.26, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 25, 2024 | 0.25 |
Fundamentals
CGON:
$6.28B
DY:
$12.04B
CGON:
-$1.59
DY:
$10.48
CGON:
1.12K
DY:
1.91
CGON:
5.51
DY:
6.43
CGON:
$5.07M
DY:
$6.25B
CGON:
-$2.54M
DY:
$1.23B
CGON:
-$191.51M
DY:
$1.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CGON vs. DY — Risk / Return Rank
CGON
DY
CGON vs. DY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CG Oncology, Inc (CGON) and Dycom Industries, Inc. (DY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CGON | DY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.90 | ||
| Sortino ratioReturn per unit of downside risk | +1.93 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.21 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 6.12 | 1.62 | +4.50 |
| Martin ratioReturn relative to average drawdown | 19.55 | 4.91 | +14.64 |
Loading charts...
Drawdowns
CGON vs. DY - Drawdown Comparison
The maximum CGON drawdown since its inception was -67.47%, smaller than the maximum DY drawdown of -93.54%. Use the drawdown chart below to compare losses from any high point for CGON and DY.
Loading charts...
Drawdown Indicators
| CGON | DY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.47% | -93.54% | +26.07% |
Max Drawdown (1Y)Largest decline over 1 year | -27.41% | -30.51% | +3.10% |
Max Drawdown (3Y)Largest decline over 3 years | — | -32.58% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -33.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -89.01% | — |
Current DrawdownCurrent decline from peak | -5.38% | -25.06% | +19.68% |
Average DrawdownAverage peak-to-trough decline | -24.86% | -45.56% | +20.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.57% | 10.06% | -1.49% |
Volatility
CGON vs. DY - Volatility Comparison
The current volatility for CG Oncology, Inc (CGON) is 15.19%, while Dycom Industries, Inc. (DY) has a volatility of 19.81%. This indicates that CGON experiences smaller price fluctuations and is considered to be less risky than DY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CGON | DY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.19% | 19.81% | -4.62% |
Volatility (6M)Calculated over the trailing 6-month period | 34.97% | 42.94% | -7.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.21% | 50.41% | +7.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.95% | 44.18% | +21.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.95% | 53.32% | +12.63% |
Dividends
CGON vs. DY - Dividend Comparison
Neither CGON nor DY has paid dividends to shareholders.
Financials
CGON vs. DY - Financials Comparison
This section allows you to compare key financial metrics between CG Oncology, Inc and Dycom Industries, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CGON and DY have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DY has higher volatility (19.81%) compared to CGON (15.19%). In terms of maximum drawdown, CGON dropped -67.47% vs DY's -93.54%.
CGON currently has the higher Sharpe Ratio (2.88 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CGON and DY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer